HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Clinical trials for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame throat cancer with fewer side effects
Disease control Not yet recruitingThis study tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation is safe and effective for early-stage HPV-positive throat cancer. About 35 adults will take the drug daily for 10 days and receive one radiation treatment, followed by standard surger…
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: John Lukens • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Could less radiation be better for HPV throat cancer? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether lowering radiation doses to certain areas can reduce side effects for people with HPV-related oropharyngeal cancer, which often has good outcomes. About 132 participants will receive either reduced lymph node radiation, reduced tumor radiation, or both, b…
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC